DIREXION SHS ETF TR's ticker is CURE and the CUSIP is 25459Y876. A total of 22 filers reported holding DIREXION SHS ETF TR in Q2 2023. The put-call ratio across all filers is 1.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $10,001 | – | 100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bullseye Investment Management, LLC | 51,862 | $4,591,343 | 3.73% |
| Traynor Capital Management, Inc. | 10,020 | $887,089 | 0.11% |
| Onyx Bridge Wealth Group LLC | 2,612 | $231,203 | 0.05% |
| Covestor Ltd | 203 | $18 | 0.01% |
| Tower Research Capital LLC (TRC) | 1,603 | $141,914 | 0.00% |
| Headlands Technologies LLC | 58 | $5,135 | 0.00% |
| GTS SECURITIES LLC | 21,736 | $1,922,950 | 0.00% |
| Quantbot Technologies LP | 262 | $23,195 | 0.00% |
| GOLDMAN SACHS GROUP INC | 37,525 | $3,322,088 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 37,700 | $3,337,581 | 0.00% |